an-69 has been researched along with Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arzuaga, A; Corral, E; Gascón, AR; Isla, A; Maynar, J; Pedraz, JL; Sánchez-Izquierdo, JA | 1 |
| Arzuaga, A; Gascón, AR; Isla, A; Maynar, J; Pedraz, JL; Sánchez-Izquierdo, JA | 1 |
2 trial(s) available for an-69 and Kidney Diseases
| Article | Year |
|---|---|
Meropenem and continuous renal replacement therapy: in vitro permeability of 2 continuous renal replacement therapy membranes and influence of patient renal function on the pharmacokinetics in critically ill patients.
Topics: Acrylic Resins; Acrylonitrile; Adult; Aged; Aged, 80 and over; Alkanesulfonates; Anti-Bacterial Agents; Female; Hemodiafiltration; Hemofiltration; Humans; Kidney Diseases; Male; Membranes, Artificial; Meropenem; Middle Aged; Permeability; Polymers; Sulfones; Thienamycins | 2005 |
In vitro AN69 and polysulphone membrane permeability to ceftazidime and in vivo pharmacokinetics during continuous renal replacement therapies.
Topics: Acrylic Resins; Acrylonitrile; Adult; Albumins; Anti-Bacterial Agents; Ceftazidime; Hemodiafiltration; Hemofiltration; Humans; Isotonic Solutions; Kidney Diseases; Male; Membranes, Artificial; Middle Aged; Permeability; Plasma; Polymers; Ringer's Lactate; Sulfones | 2007 |